Search research articles
Contact Us
Filters
Showing results (111-120 of 205) with videos related to
Page
of 21
Sort By:
The New England Journal of Medicine
|
May 7, 1987
Human immunodeficiency virus type 2 infection associated with AIDS in West Africa
F Clavel, K Mansinho, S Chamaret, et al.
The European Respiratory Journal
|
June 11, 2011
Farming in childhood, diet in adulthood and asthma history
R Varraso, M P Oryszczyn, N Mathieu, et al.
Diabetologia
|
July 25, 2009
Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort
B de Lauzon-Guillain, A Fournier, A Fabre, et al.
Journal of Virology
|
June 20, 2001
Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy
A J Hance, V Lemiale, J Izopet, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie
|
January 1, 1986
[LAV type II: a second retrovirus associated with AIDS in West Africa]
F Clavel, F Brun-Vézinet, D Guétard, et al.
Lancet (London, England)
|
January 17, 1987
Lymphadenopathy-associated virus type 2 in AIDS and AIDS-related complex. Clinical and virological features in four patients
F Brun-Vezinet, M A Rey, C Katlama, et al.
AIDS (London, England)
|
August 17, 1999
Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy
C Piketty, E Race, P Castiel, et al.
Gut
|
December 1, 1987
Cholangitis in the acquired immunodeficiency syndrome: report of two cases and review of the literature
D Roulot, D Valla, F Brun-Vezinet, et al.
AIDS (London, England)
|
April 26, 2000
Phenotypic resistance to protease inhibitors in patients who fail on highly active antiretroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz
C Piketty, E Race, P Castiel, et al.
Human Reproduction (Oxford, England)
|
June 8, 2017
Associations among body size across the life course, adult height and endometriosis
L V Farland, S A Missmer, A Bijon, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 205) with videos related to
Sort By:
Page
of 21
The New England Journal of Medicine
|
May 7, 1987
Human immunodeficiency virus type 2 infection associated with AIDS in West Africa
F Clavel, K Mansinho, S Chamaret, et al.
The European Respiratory Journal
|
June 11, 2011
Farming in childhood, diet in adulthood and asthma history
R Varraso, M P Oryszczyn, N Mathieu, et al.
Diabetologia
|
July 25, 2009
Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort
B de Lauzon-Guillain, A Fournier, A Fabre, et al.
Journal of Virology
|
June 20, 2001
Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy
A J Hance, V Lemiale, J Izopet, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie
|
January 1, 1986
[LAV type II: a second retrovirus associated with AIDS in West Africa]
F Clavel, F Brun-Vézinet, D Guétard, et al.
Lancet (London, England)
|
January 17, 1987
Lymphadenopathy-associated virus type 2 in AIDS and AIDS-related complex. Clinical and virological features in four patients
F Brun-Vezinet, M A Rey, C Katlama, et al.
AIDS (London, England)
|
August 17, 1999
Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy
C Piketty, E Race, P Castiel, et al.
Gut
|
December 1, 1987
Cholangitis in the acquired immunodeficiency syndrome: report of two cases and review of the literature
D Roulot, D Valla, F Brun-Vezinet, et al.
AIDS (London, England)
|
April 26, 2000
Phenotypic resistance to protease inhibitors in patients who fail on highly active antiretroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz
C Piketty, E Race, P Castiel, et al.
Human Reproduction (Oxford, England)
|
June 8, 2017
Associations among body size across the life course, adult height and endometriosis
L V Farland, S A Missmer, A Bijon, et al.
Page
of 21